Presenter: James Greenblatt, MD
Format: 1 hr webinar recording
Registration: FREE (accessible for 90 days)
Recording Date: August 2021
Alzheimer’s disease and other forms of dementia represent the 6th leading cause of death in the U.S., and the only cause amongst the top ten that cannot be cured or curtailed through pharmaceutical intervention. Despite decades’ worth of research, viable treatment solutions for Alzheimer’s, dementia, and cognitive decline continue to elude modern medicine.
In this webinar, Dr. James Greenblatt will explore the pathogenesis of Alzheimer’s from a systems neurobiology framework, highlighting biochemical abnormalities that research has robustly associated with symptomatic presentations. He will focus on homocysteine and low-dose lithium – the former an internationally-acknowledged risk factor for Alzheimer’s that can be mitigated with B-vitamins, and the latter a natural, essential mineral that happens also to be a neuroprotective powerhouse.
He will review studies supporting the use of homocysteine mitigation and low-dose lithium supplementation, as well as mechanisms underlying lithium’s anti-inflammatory and neuroprotective effects. Finally, he will provide evidence-based recommendations for the use of B-vitamins and low-dose lithium, providing attendees with clinical pearls that they may incorporate into existing protocols to maximize therapeutic outcomes.
Webinar sponsored by LumaTC
Stay in the know.
Sign-up now for updates, news and exclusive offers! Let’s redefine mental wellness together.
By submitting your information, you agree to receive future email communications from us. We promise to keep your information private, and you can easily unsubscribe at any time.